Nuveen
QTTB icon

Nuveen’s Q32 Bio QTTB Stock Holding History

Nuveen’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$472 Buy
+317
New +$4.39K ﹤0.01% 4988
2025
Q2 		– Sell
-55,886
Closed -$92.2K – 3439
2025
Q1 		$92.2K Hold
55,886
– – ﹤0.01% 3222
2024
Q4 		$192K Hold
55,886
– – ﹤0.01% 3211
2024
Q3 		$2.49M Buy
+55,886
New +$2.05M ﹤0.01% 2313
2022
Q2 		– Sell
-10,977
Closed -$664K – 3515
2022
Q1 		$664K Buy
10,977
+784
+8% +$48.7K ﹤0.01% 2932
2021
Q4 		$668K Sell
10,193
-619
-6% -$60.1K ﹤0.01% 2991
2021
Q3 		$1.53M Sell
10,812
-2,605
-19% -$332K ﹤0.01% 2798
2021
Q2 		$1.76M Buy
13,417
+5,722
+74% +$714K ﹤0.01% 2774
2021
Q1 		$1.3M Buy
7,695
+234
+3% +$49.3K ﹤0.01% 2797
2020
Q4 		$1.52M Buy
7,461
+395
+6% +$76.3K ﹤0.01% 2640
2020
Q3 		$1.36M Buy
7,066
+36
+0.5% +$8.07K ﹤0.01% 2548
2020
Q2 		$1.92M Buy
7,030
+1,851
+36% +$493K ﹤0.01% 2355
2020
Q1 		$1.45M Sell
5,179
-16
-0.3% -$4.9K ﹤0.01% 2349
2019
Q4 		$1.94M Buy
5,195
+12
+0.2% +$3.44K ﹤0.01% 2429
2019
Q3 		$1.69M Buy
5,183
+134
+3% +$45.5K ﹤0.01% 2480
2019
Q2 		$1.78M Buy
+5,049
New +$1.98M ﹤0.01% 2480

Other funds holding QTTB

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $444M AUM 151.5% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Nuveen's QTTB Position: Q3 2026 in Review

Nuveen opened a new position in Q32 Bio (QTTB) in Q3 2026: 317 shares worth $472. The stake represents ﹤0.01% of the portfolio and ranks #4988 among its holdings. This is a return to the name: Nuveen previously reported a position in QTTB as recently as Q1 2025.

Nuveen first reported a position in QTTB in Q2 2019 and has held it in 16 quarters since. The position peaked at $2.49M in Q3 2024. 27 funds tracked by Wall St. Rank hold QTTB as of Q3 2026.

  • Nuveen held 317 shares of Q32 Bio worth $472 as of Q3 2026.
  • Q32 Bio was a new Nuveen position in Q3 2026.
  • Q32 Bio made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4988 holding.
  • Nuveen first reported a position in Q32 Bio in Q2 2019 and has held it in 16 quarters since.
  • Nuveen's Q32 Bio position peaked at $2.49M in Q3 2024.
  • 27 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.